MonoRab™ Anti-Adalimumab Antibody (134D5), mAb, Rabbit

The product is specific for Adalimumab. This antibody blocks Adalimumab binding with TNF-α (Z01001, TNF-α, Human) in ELISA. The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01921-40, MonoRab™ Anti-Adalimumab Antibody (4E12), mAb, Rabbit.

价格	￥1980 在线订购包邮(港澳台除外)
产品编号	A01922-40
规格	40 μg 大单询价
数量
参考货期


咨询产品问题

产品概述应用指导产品属性图例技术背景

产品概述

Specificity	The product is specific for Adalimumab. This antibody blocks Adalimumab binding with TNF-α (Z01001, TNF-α, Human) in ELISA. The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01921-40, MonoRab™ Anti-Adalimumab Antibody (4E12), mAb, Rabbit.
Host Species	Rabbit
Immunogen	Adalimumab
Conjugate	Unconjugated

应用指导

Working concentrations for specific applications should be determined by the investigators. The appropriate concentration may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.

Application	Recommended Usage
ELISA	0.01-0.1 µg/ml

产品属性

Form	Lyophilized
Storage Buffer	lyophilized with PBS, pH 7.4, containing 0.02% sodium azide.
Reconstitution	Reconstitute the lyophilized powder with deionized water (or equivalent) to an final concentration of 0.5 mg/mL.
Storage Instructions	The lyophilized product remains stable for 1 year at -20℃ from the date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8℃ or for 12 months at -20℃ or below. Avoid freeze/thaw cycles.
Purification	Protein A affinity column
Isotype	Rabbit IgG
Clonality	Monoclonal
Clone ID	134D5
Note	GenScript can customize this product per customer's request including product size, buffer components, etc.

图例

MonoRab™ Anti-Adalimumab Antibody (134D5), MAb, Rabbit

ELISA binding of MonoRabᵀᴹ Anti-Adalimumab Antibody (134D5), mAb, Rabbit (GenScript, A01922-40) with Adalimumab. While the antibody does not recognize the human IgG Fc fragment (data not shown).
Coating antigen: Adalimumab, 0.8 µg/ml.
Anti-Adalimumab antibody (GenScript, A01922-40) dilution start from 1,000 ng/ml.
EC₅₀= 7.295 ng/ml. »

MonoRabᵀᴹ Anti-Adalimumab Antibody (134D5), mAb, Rabbit (GenScript, A01922-40) blocks Adalimumab binding with TNF-α. Coating antigen: Adalimumab, 0.5 µg/ml.
Anti-Adalimumab Antibody (134D5), mAb, Rabbit (GenScript, A01922-40) final concentration: 3.5 ng/ml.
TNF-α dilution start from 50 µg/ml.
IC₅₀= 353.1 ng/ml. »

Standard curve of Adalimumab Sandwich ELISA. The Adalimumab Sandwich ELISA assay is developed by using MonoRabᵀᴹ Anti-Adalimumab Antibody (4E12), mAb, Rabbit (GenScript, A01921-40) and MonoRabᵀᴹ Anti-Adalimumab Antibody (134D5), mAb, Rabbit (GenScript, A01922-40) as the capture and detection antibodies, respectively. These two antibodies could be used to development Sandwich ELISA Kit.
In this ELISA assay, MonoRabᵀᴹ Anti-Adalimumab Antibody (134D5), mAb, Rabbit (GenScript, A01922-40) was labeled with Biotin. GenScript can provide customized conjugation services for this product per customer's request.
The sensitivity is < 2 ng/ml and the detection range is 0-33 ng/ml. »

技术背景

Target Background

Adalimumab (Humira) is a humanized monoclonal antibody that’s approved by the U.S. Food and Drug Administration for the treatment of patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic psoriasis, hidradenitis suppurativa, and juvenile idiopathic arthritis. Adalimumab binds to the TNF-α (tumor necrosis factor-alpha), and blocks its interaction with TNF-α receptors, reducing the inflammatory response of autoimmune diseases.

Synonyms

Rabbit monoclonal to Humira

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.